HUTCHMED (China) Ltd (HCM) shareholders
Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HCM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Schroder Investment Management Group | 1,477,494 | – | $15.82M | – | 0.01% |
| Allianz Asset Management GmbH | 837,475 | – | $12.53M | – | 0.01% |
| State Street Corp | 313,611 | – | $3.37M | +8,782 | 0.00% |
| AIA Group Ltd | 291,229 | – | $3.13M | – | 0.04% |
| M&g PLC | 242,791 | – | $2.67M | −12,677 | 0.01% |
| Amundi | 204,385 | – | $2.20M | −27,861 | 0.00% |
| Jane Street Group, LLC | 194,472 | – | $2.09M | +117,958 | 0.00% |
| Renaissance Technologies LLC | 130,200 | – | $1.40M | −1,862 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 104,425 | – | $1.12M | −2,079 | 0.00% |
| XY Capital Ltd | 104,130 | – | $1.12M | +55,736 | 1.08% |
| Crossmark Global Holdings, Inc. | 84,915 | – | $913.69K | −48 | 0.01% |
| Acadian Asset Management LLC | 65,166 | – | $696.00K | +65,157 | 0.00% |
| Two Sigma Investments, LP | 63,248 | – | $680.55K | New | 0.00% |
| UBS Group AG | 44,183 | – | $475.41K | −575 | 0.00% |
| Vanguard Personalized Indexing Management, LLC | 42,599 | – | $458.37K | +22,174 | 0.00% |
| Dimensional Fund Advisors LP | 38,967 | – | $419.29K | −17,002 | 0.00% |
| Citadel Advisors LLC | 38,061 | – | $409.54K | +7,547 | 0.00% |
| Vident Advisory, LLC | 26,584 | – | $286.04K | +8,858 | 0.00% |
| Millennium Management LLC | 26,420 | – | $284.28K | −1,594 | 0.00% |
| StoneX Group Inc. | 18,262 | – | $213.56K | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 4M | 8 / 15 | 22 / 5 | 0M | 0M |
| Q1 2026 | 54 | 4M | 9 / 14 | 19 / 4 | 0M | 1M |
| Q4 2025 | 50 | 5M | 3 / 16 | 17 / 11 | 0M | 1M |
| Q3 2025 | 58 | 6M | 3 / 19 | 22 / 8 | 0M | 1M |
| Q2 2025 | 63 | 6M | 8 / 19 | 20 / 8 | 0M | 1M |
| Q1 2025 | 63 | 7M | 2 / 17 | 31 / 8 | 0M | 1M |
| Q4 2024 | 69 | 7M | 10 / 17 | 25 / 7 | 1M | 1M |
| Q3 2024 | 66 | 7M | 8 / 18 | 20 / 8 | 0M | 2M |
| Q2 2024 | 67 | 9M | 11 / 16 | 26 / 15 | 0M | 6M |
| Q1 2024 | 71 | 15M | 10 / 22 | 25 / 9 | 1M | 1M |
| Q4 2023 | 71 | 15M | 7 / 22 | 26 / 1 | 1M | 9M |
| Q3 2023 | 65 | 23M | 9 / 14 | 23 / 14 | 1M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
9 funds held HCM in Q2 2026, 54% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of HCM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Steward Values Enhanced International Fund | 84,097 | – | $936.00K | 0.28% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 70,063 | – | $753.88K | 0.00% | Jun 30, 2026 |
| Tema Oncology ETF | 67,823 | – | $776.57K | 0.44% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 21,833 | – | $249.99K | 0.00% | May 31, 2026 |
| National Security Emerging Markets Index ETF | 7,512 | – | $86.01K | 0.21% | May 31, 2026 |
| Dimensional Emerging Markets Core Equity 2 ETF | 5,574 | – | $62.04K | 0.00% | Jul 31, 2026 |
| Dimensional World ex. U.S. Core Equity 2 ETF | 2,110 | – | $23.48K | 0.00% | Jul 31, 2026 |
| Emerging Markets Core Equity 2 Portfolio | 1,681 | – | $18.71K | 0.00% | Jul 31, 2026 |
| Dimensional Emerging Markets Sustainability Core 1 ETF | 1,312 | – | $14.60K | 0.00% | Jul 31, 2026 |
| Emerging Markets Sustainability Core 1 Portfolio | 1,241 | – | $13.81K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO, Director | 56,693 | May 21, 2026 |
| Wei-guo Su | CEO and CSO, Director | 3,563,905 | May 21, 2026 |
| Charles George Rupert Nixon | Group General Counsel | 41,763 | May 21, 2026 |
| Lorenso Chiu | Deputy Chief Financial Officer | 8,475 | May 21, 2026 |
| Renu Bhatia | Director | 16,000 | Mar 10, 2026 |
| Ling Yang | Director | – | Mar 10, 2026 |
| Tak Wai Wong | Director | – | Mar 10, 2026 |
| Daniel Shao Weng Tan | Director | – | Mar 10, 2026 |
| Dan Eldar | Director | 19,000 | Mar 10, 2026 |
| Chaohong Hu | Director | – | Mar 10, 2026 |
| Edith Shih | Director | 100,000 | Mar 10, 2026 |
| Tony Shu Kam Mok | – | 27,341 | May 13, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of HUTCHMED (China)'s stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,079 shares on Oct 8, 2026 over the last 90 days.
See a number that looks wrong?